Vitenskapelig artikkel

• Tale Litlere Bjerknes; Ole Martin Steihaug; Mette Haugen et al. (2022). Case report: Pain in anti-DPPX encephalitis. (ekstern lenke)
• L. Bjørge; T. Skeie Jensen; E. Ulvestad et al. (1995). The influence of tumour necrosis factor-_a, interleukin-1_b and interferon-_g on the expression and function of the complement regulatory protein CD59 on the human colonic adenocarcinoma cell line HT29. (ekstern lenke)
• Christian A. Vedeler; E Ulvestad; L Bjørge et al. (1994). The expression of CD59 in normal human nervous tissue. (ekstern lenke)
• E Ulvestad; K Williams; Christian A. Vedeler et al. (1994). Reactive microglia in multiple sclerosis lesions have an increased expression of receptors for the Fc part of IgG. (ekstern lenke)
• B. Karlsen; Christian A. Vedeler (1996). Guillain-Barré syndrom; tema med variasjoner. (ekstern lenke)
• W.P. Howlett; Christian A. Vedeler; H. Nyland et al. (1996). Guillain-Barré syndrome in northern Tanzania: a comparison of epidemical and clinical findings with western Norway. (ekstern lenke)
• Nils Erik Gilhus; Ole-Bjørn Tysnes; Christian A. Vedeler (2006). Bergen International symposium in neuroimmunology 2006. Introduction. (ekstern lenke)
• Christian A. Vedeler; E. Wiik; Harald Nyland (1997). The long-term prognosis of Guillain-Barré syndrome.Evaluation of prognostic factors including plasma exchange. (ekstern lenke)
• Fredrik Romi; Christian A. Vedeler; Ole-Bjørn Tysnes et al. (2000). Polynevropati er et tidlig funn ved primært systemisk amyloidose. (ekstern lenke)
• J Lunding; Rune Midgard; Christian A. Vedeler (2000). Oligoclonal bands in cerebrospinal fluid: a comparative study of isoelectric focusing, agarose gel electrophoresis and IgG index. (ekstern lenke)
• HJ Willison; W Ang; Nils Erik Gilhus et al. (2000). EFNS Task Force Report: a questionnaire-based survey on the service provision and quality assurance for determination of diagnostic autoantibody tests in European neuroimmunology centres. (ekstern lenke)
• Kjell-Morten Myhr; MD Ross; Harald Inge Nyland et al. (2000). Neutralizing antibodies to interferon (IFN)alfa-2a and IFN beta-1a or IFN beta-1b in MS are not cross-active. (ekstern lenke)
• Charalampos Tzoulis; Christian A. Vedeler; Mette Haugen et al. (2013). Progressive striatal necrosis associated with anti-NMDA receptor antibodies. (ekstern lenke)
• Christian A. Vedeler; Roald Matre; Einar Klæboe Kristoffersen et al. (1991). IgG Fc receptor heterogeneity in human peripheral nerves. (ekstern lenke)
• G. Conti; Christian A. Vedeler; P. Bannerman et al. (1992). Peripheral nervous system (PNS) expression of mRNAs encoding myelin proteins and FC RIII during experimental allergic neuritis. (ekstern lenke)
• Christian A. Vedeler; G. Conti; P. Bannermann et al. (1992). Expression of Genes Encoding Receptors for IgG (FcRIII) and for C3b/Cb4 (Crry) in Rat Sciatic Nerve During Development and Wallerian Degeneration. (ekstern lenke)
• Ellen M Hagen; Ivar Otto Gjerde; Christian A. Vedeler et al. (2000). Nevrologisk sykdom assosiert med cøliaki. (ekstern lenke)
• Kjell-Morten Myhr; S Sadallah; Tom Eirik Mollnes et al. (2000). Interferon-alfa2a effects on complement and regulation in MS patients. (ekstern lenke)
• Christian A. Vedeler; Kjell-Morten Myhr; Guttorm Raknes et al. (2000). IgG Fc-receptor polymorphisms in Guillain-Barre syndrome. (ekstern lenke)
• Christian A. Vedeler (2000). Inflammatory neuropathies: update. (ekstern lenke)
• Fredrik Romi; Geir Olve Skeie; Christian A. Vedeler et al. (2000). Complement activation by titin and ryanodine receptor autoantibodies in myasthenia gravis. (ekstern lenke)
• Kjell-Morten Myhr; Trond Riise; F.E.G Lilleås et al. (1999). Interferon-alpha 2a reduces MRI disease activity in relapsing-remittingmultiple sclerosis. (ekstern lenke)
• Christian A. Vedeler; Roald Matre; S. Sadallah et al. (1996). Soluble complement receptor type 1 in serum and cerebrospinal fluid of patients with Guillain-Barre syndrome and multiple sclerosis. (ekstern lenke)
• Ingerid Skarstein; Elling Ulvestad; Anne Marit Solheim et al. (2024). Serum neurofilament light chain associates with symptom burden in Lyme neuroborreliosis patients: a longitudinal cohort study from Norway. (ekstern lenke)
• Ivar Otto Gjerde; Nina Karin Aarskog; Christian A. Vedeler (2001). Hereditær nevropati med trykkpareser. (ekstern lenke)
• Magne Solberg Nes; Christian Alexander Vedeler (2023). En mann i 50-årene med nærbesvimelser og vedvarende svimmelhet. (ekstern lenke)
• Ulrike Waje-Andreassen; Halvor Næss; Lars Thomassen et al. (2015). Biomarkers related to carotid intima-media thickness and plaques in long-term survivors of ischemic stroke. (ekstern lenke)
• Ellen Færgestad Mosleth; Christian Alexander Vedeler; Kristian Hovde Liland et al. (2021). Cerebrospinal fluid proteome shows disrupted neuronal development in multiple sclerosis. (ekstern lenke)
• Sonia Gavasso; Ellen Færgestad Mosleth; Tove Helene Marøy et al. (2014). Deficient phosphorylation of stat-1 in leukocytes identifies neutralizing antibodies in multiple sclerosis patients treated with interferon-beta. (ekstern lenke)
• Cecilie Totland; Mette Haugen; Christian Alexander Vedeler (2021). CRMP5 Antibodies—Diagnostic Challenges. (ekstern lenke)
• Christian A. Vedeler (2004). Recommended diagnostic criteria for paraneoplastic neurological syndromes. (ekstern lenke)
• Kristin Nielsen Varhaug; Christian Barro; Kjetil Lauvland Bjørnevik et al. (2017). Neurofilament light chain predicts disease activity in relapsing-remitting MS. (ekstern lenke)
• Frode Berven; Ann Cathrine Kroksveen; Magnus Foldal Berle et al. (2007). Pre-analytical influence on the low molecular weight cerebrospinal fluid proteome. (ekstern lenke)
• Ellen M. Hagen; Ivar Otto Gjerde; Christian A. Vedeler et al. (2000). Nevrologisk sykdom assosiert med cøliaki. (ekstern lenke)
• Tor Hatlestad Qvale; Anette Storstein; Kibret Yimer Mazengia et al. (2014). Paraneoplastic Hu and CRMP5 antibodies are present in smokers without cancer or neurological disease. (ekstern lenke)
• Kjell-Morten Myhr; Trond Riise; Elizabeth Barrett-Connor et al. (1998). Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway. (ekstern lenke)
• P. Fredman; Christian A. Vedeler; H. Nyland et al. (1991). Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin. (ekstern lenke)
• Christian A. Vedeler; L. Fitzpatrick-Kløve (1990). Receptors for immunoglobulines demonstrated on human peripheral nerve fibres by electron microscopy. (ekstern lenke)
• Christian A. Vedeler; L. Thomassen; E. Skaarland (1990). Mollarets meningitt. (ekstern lenke)
• Sissel Evy Monstad; Anette Margrethe Storstein; Anne Dørum et al. (2006). Yo antibodies in ovarian and breast cancer patients detected by a sensitive immunoprecipitation technique. (ekstern lenke)
• Anette Margrethe Storstein; Sissel Evy Monstad; Mette Haugen et al. (2011). Onconeural antibodies: Improved detection and clinical correlations. (ekstern lenke)
• Ida Ajvazi Herdlevær; Mette Haugen; Kibret Yimer Mazengia et al. (2021). Paraneoplastic Cerebellar Degeneration: The Importance of Including CDR2L as a Diagnostic Marker. (ekstern lenke)
• Francesc Graus; Alberto Vogrig; Sergio Muñiz-Castrillo et al. (2021). Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes. (ekstern lenke)
• Kjell Inge Erikstad; Ida Ajvazi Herdlevær; Elise Marie Peter et al. (2023). A cerebellar degeneration-related protein 2-like cell-based assay for anti-Yo detection in patients with paraneoplastic cerebellar degeneration. (ekstern lenke)
• Christian A. Vedeler (2000). Inflammatory neuropathies: update. (ekstern lenke)
• Christian A. Vedeler; Roald Matre; Einar Klæboe Kristoffersen et al. (1991). IgG Fc receptor heterogeneity in human peripheral nerves. (ekstern lenke)
• Christian A. Vedeler; Roald Matre (1990). Peripheral nerve CR1 limit complement-mediated haemolysis. (ekstern lenke)
• J Lunding; R. Midgard; Christian A. Vedeler (2000). Oligoclonal bands in cerebrospinal fluid: a comparative study of isoelectric focusing, agarose gel electrophoresis and IgG index. (ekstern lenke)
• Nina Karin Aarskog; Christian A. Vedeler (2000). Real-time quantitative polymerase chain reaction. A new method that detects both the peripheral myelin protein 22 duplication in Charcot-Marie-Tooth type 1A disease and the peripheral myelin protein 22 deletion in hereditary neuropathy with liability to pressure palsies. (ekstern lenke)
• Fredrik Romi; Geir Olve Skeie; Christian A. Vedeler et al. (2000). Complement activation by titin and ryanoidine receptor autoantibodies in myasthenia gravis. (ekstern lenke)
• Kjell-Morten Myhr; MD Ross; Harald Inge Nyland et al. (2000). Neutralizing antibodies to interferon (IFN)alfa-2a and IFN beta-1a or IFN beta-1b in MS are not cross-active. (ekstern lenke)
• Annette Fromm; Lars Thomassen; Halvor Næss et al. (2013). The Norwegian stroke in the young study (NOR-SYS): rationale and design. (ekstern lenke)
• Reidar Arneberg; Tarja Rajalahti; Kristian Flikka et al. (2007). Pretreatment of mass spectral profiles: Application to proteomic data. (ekstern lenke)
• Kjell-Morten Myhr; S Sadallah; Tom Eirik Mollnes et al. (2000). Inerteron-alfa2a effects on complement and regulation in MS patients. (ekstern lenke)
• Kjell-Morten Myhr; S Sadallah; Tom Eirik Mollnes et al. (2000). Inerteron-alfa2a effects on complement and regulation in MS patients. (ekstern lenke)
• Christian A. Vedeler; Kjell-Morten Myhr; Guttorm Raknes et al. (2000). IgG Fc-receptor polymorphisms in Guillain-Barre syndrome. (ekstern lenke)
• Fredrik Romi; Christian A. Vedeler; Ole-Bjørn Tysnes et al. (2000). Polynevropati er et tidlig funn ved primært systemisk amyloidose. (ekstern lenke)
• Kristin Varhaug; Christian A. Vedeler; Kjell-Morten Myhr et al. (2016). Increased levels of cell-free mitochondrial DNA in the cerebrospinal fluid of patients with multiple sclerosis. (ekstern lenke)
• O Torkildsen; Øivind Fredvik Torkildsen; Egil Utsi et al. (2005). Ethnic variations of IL-10 polymorphisms in a Sami and Norwegian population. (ekstern lenke)
• Emilia Børhaug; Christian Alexander Vedeler (2021). Nevrosarkoidose – en pasientserie. (ekstern lenke)
• Tiina Rekand; Arne Gramstad; Christian A. Vedeler (2009). Fatigue, pain and muscle weakness are frequent after Guillain-Barré syndrome and poliomyelitis. (ekstern lenke)
• Margrethe Raspotnig; Torbjørn Kråkenes; Ida Ajvazi Herdlevær et al. (2022). Expression of cerebellar degeneration-related proteins CDR2 and CDR2L in human and rat brain tissue. (ekstern lenke)
• Ulrike Waje-Andreassen; Halvor Næss; Lars Thomassen et al. (2008). Ultrasound, atherosclerosis and stroke at a young age: a cross-sectional long-term follow-up in western Norway. (ekstern lenke)
• Cecilie Totland; Ming Ying; Mette Haugen et al. (2013). Avidity of onconeural antibodies is of clinical relevance. (ekstern lenke)
• E.D Pedersen; U Waje-Andreassen; Christian A. Vedeler et al. (2004). Systemic complement activation following human acute ischaemic stroke. (ekstern lenke)
• Øivind Fredvik Torkildsen; Christian A. Vedeler; Elling Ulvestad et al. (2005). High dose methylprednisolone induces FcgammaR1 on granulocytes in MS-patients. (ekstern lenke)
• Anette Storstein; Christian A. Vedeler (2005). Neurological symptoms as the first sign of cancer: Paraneoplastic encephalomyelitis and sensory neuronopathy. (ekstern lenke)
• Christian A. Vedeler; Elisabeth Farbu; Svein Ivar Mellgren (2013). Chronic inflammatory demyelinating polyneuropathy (CIDP). (ekstern lenke)
• O Torkildsen; Øivind Fredvik Torkildsen; Egil Utsi et al. (2005). Ethnic variation of Fc gamma receptor polymorphism in Sami and Norwegian populations. (ekstern lenke)
• Sonia Gavasso; Ottar Nygård; Eva Kristine Ringdal Pedersen et al. (2005). Fc gamma receptor IIIA polymorphism as a risk-factor for coronary artery disease. (ekstern lenke)
• Anette Storstein; Anette Knudsen; Christian A. Vedeler (2005). Proteasome antibodies in paraneoplastic cerebellar degeneration. (ekstern lenke)
• Ann Cathrine Kroksveen; Elise Aasebø; Heidrun Vethe et al. (2013). Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM. (ekstern lenke)
• A. Storstein; Sissel Evy Monstad; J Honnorat et al. (2004). Paraneoplastic antibodies detected by isoelectric focusing of cerebrospin fluid and serum. (ekstern lenke)
• A. Storstein; Anette Knudsen; Line Bjørge et al. (2004). Heterogeneous expression of CD59 on human Purkinje cells. (ekstern lenke)
• Sonia Gavasso; Øivind Torkildsen; Tove Helene Marøy et al. (2012). Fcγ receptors in Norwegian multiple sclerosis patients and healthy controls. (ekstern lenke)
• Johan G Brun; TM Madland; Christian A. Vedeler (1999). Immunoglobulin G, Fc-receptor IIA and IIB plymorphisms related to disease severity in rheumatoid arthritis. (ekstern lenke)
• Øivind Fredvik Torkildsen; Christian A. Vedeler; Harald Inge Nyland et al. (2006). Fc gamma R and multiple sclerosis: an overview. (ekstern lenke)
• Sonia Gavasso; Kjell-Morten Myhr; Christian A. Vedeler (2006). Multiplexed phosphoprotein analysis in immune cells. (ekstern lenke)
• Christian A. Vedeler; E. Ulvestad; I. Grundt et al. (1993). Fc receptor for IgG (FcR) on rat microglia. (ekstern lenke)
• S.E Monstad; L Drivsholm; A. Storstein et al. (2004). Hu and voltage-gated calcium channel (VGCC) antibodies related to the prognosis of small-cell lung cancer. (ekstern lenke)
• Elling Ulvestad; J.H Aarseth; Christian A. Vedeler et al. (2004). The effects of interferon-alpha2a on concentrations of immunoglobulins, complement and lymphocytes in patients with multiple sclerosis. (ekstern lenke)
• Margrethe Raspotnig; Christian A. Vedeler; Anette Storstein (2011). Onconeural antibodies in patients with neurological symptoms: detection and clinical significance. (ekstern lenke)
• Christian A. Vedeler; E. Ulvestad; L. Bjørge et al. (1994). The expression of CD59 in normal human nervous tissue. (ekstern lenke)
• Christian A. Vedeler; E. Ulvestad; I. Grundt et al. (1994). Fc receptor for IgG (FcR) on rat microglia. (ekstern lenke)
• Anette Knudsen; Christian A. Vedeler (2006). cDNA expression library screening for identification of novel onconeural antigens. (ekstern lenke)
• Sissel Evy Monstad; Christian A. Vedeler (2006). An immunprecipitation assay for the detection of onconeural antibodies. (ekstern lenke)
• Anette Margrethe Storstein; Bård Kronen Krossnes; Christian A. Vedeler (2006). Autopsy findings in the nervous system and ovarian tumour of two patients with paraneoplastic cerebellar degeneration. (ekstern lenke)
• Christian A. Vedeler (1991). Multippel sklerose - en immunologisk sykdom. (ekstern lenke)
• Cecilie Totland; Geir Bredholt; Mette Haugen et al. (2010). Antibody to CCDC104 is associated with a paraneoplastic antibody to CDR2 (anti-Yo). (ekstern lenke)
• E. Ulvestad; K. Williams; Christian A. Vedeler et al. (1994). Reactive microglia in multiple sclerosis lesions have an increased expression of receptors for the Fc part of IgG. (ekstern lenke)
• Einar Klæboe Kristoffersen; Roald Matre; E. Ulvestad et al. (1994). A dot-immunobinding for the demonstration of soluble Fc_g receptors. (ekstern lenke)
• A. Vatne; Christian A. Vedeler; Ole-Bjørn Tysnes et al. (1994). Varicella zoster-infeksjoner of neurologiske komplikasjoner. (ekstern lenke)
• Christian A. Vedeler (1994). Felles vaktordning for det "medisinske fagfelt", Haukeland sykehus. (ekstern lenke)
• L. Bjørge; Christian A. Vedeler; E. Ulvestad et al. (1994). Expression and function of CD59 on colonic adenocarcinoma cells. (ekstern lenke)
• Christian A. Vedeler; E. Ulvestad; H. Nyland et al. (1994). Receptors for gammablobulin in the central and preipheral nervous system. (ekstern lenke)
• Trine Almås; Christian A. Vedeler; Sverre Mørk (1998). Cerebral amyloid angiopati. (ekstern lenke)
• Anette Susanne Bøe Wolff; Kjell-Morten Myhr; Christian A. Vedeler et al. (2007). Fc gamma receptor polymorphisms are not associated with autoimmune Addison's disease. (ekstern lenke)
• Martin K.R. Svačina; Man Mohan Mehndiratta; Christian Alexander Vedeler et al. (2021). Clinical management of chronic inflammatory demyelinating polyneuropathy (CIDP) in Europe and India: An exploratory study. (ekstern lenke)
• Maria Hyunh Thuy-Tien; Margaretha Haugen; Jan Harald Aarseth et al. (2008). Proteasome antibodies in patients with cancer or multiple sclerosis. (ekstern lenke)
• Magne Solberg Nes; Christian Alexander Vedeler; Gaute Kjellevold Wathle (2023). Palatal tremor. (ekstern lenke)
• Anette Knudsen; Geir Bredholt; Anette Margrethe Storstein et al. (2007). Antibodies to CRMP3-4 associated with limbic encephalitis and thymoma. (ekstern lenke)
• Trine Almås; Christian A. Vedeler; G Moen et al. (1998). Cerebral amyloid angiopati (CAA). (ekstern lenke)
• Margrethe Raspotnig; Mette Haugen; Maria Thorsteinsdottir et al. (2017). Cerebellar degeneration-related proteins 2 and 2-like are present in ovarian cancer in patients with and without Yo antibodies. (ekstern lenke)
• Axel Petzold; Ayse Altintas; Laura Andreoni et al. (2010). Neurofilament ELISA validation. (ekstern lenke)
• Sissel Evy Monstad; Jane Kristin Nøstbakken; Christian A. Vedeler (2009). CRMP5 antibodies found in a patient with limbic encephalitis and myasthenia gravis. (ekstern lenke)
• Guttorm Raknes; Geir Olve Skeie; Nils Erik Gilhus et al. (1998). FcgRIIA and RIIIB polymorphisms in myasthenia gravis. (ekstern lenke)
• Tarja Anniki Rajalahti Kvalheim; Ann Cathrine Kroksveen; Reidar Arneberg et al. (2010). A multivariate approach to reveal biomarker signatures for disease classification: application to mass spectral profiles of cerebrospinal fluid from patients with multiple sclerosis. (ekstern lenke)
• Kjell-Morten Myhr; Trond Riise; Elizabeth Barrett-Connor et al. (1998). Altered antibody pattern to Epstein-Barr virus but not to other herpes viruses in multiple sclerosis: a population based case-control study from western Norway. (ekstern lenke)
• Anette Susanne Bøe; G. Bredholt; Per Knappskog et al. (2004). Pyridoxal phosphatase is a novel cancer autoantigen in the central nervous system. (ekstern lenke)
• A. Storstein; Sissel Evy Monstad; Hanne Linda Nakkestad et al. (2004). Paraneoplastic antibodies against HuD detected by a sensitive radiobinding assay. (ekstern lenke)
• Per Soelberg Sørensen; Poul Erik Hyldgaard Jensen; Aiden Haghikia et al. (2011). Occurrence of antibodies against natalizumab in relapsing multiple sclerosis patients treated with natalizumab. (ekstern lenke)
• Kjell-Morten Myhr; Trond Riise; Christian A. Vedeler et al. (2001). Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension. (ekstern lenke)
• Ulrike Waje-Andreassen; Halvor Næss; Lars Thomassen et al. (2007). Long-term mortality among young ischemic stroke patients in western Norway. (ekstern lenke)
• Kjell Arne Arntzen; Helle Høyer; Kristin Ørstavik et al. (2018). Charcot-Marie-Tooth disease type 4C in Norway: Clinical characteristics, mutation spectrum and minimum prevalence. (ekstern lenke)
• Maria Nordheim Alme; Agnes Elisabeth Nystad; Lars Bø et al. (2015). Fingolimod does not enhance cerebellar remyelination in the cuprizone model. (ekstern lenke)
• Eirik Tveit Solheim; Yola Gerking; Torbjørn Kråkenes et al. (2024). Multi-omics profiling reveals dysregulated ribosome biogenesis and impaired cell proliferation following knockout of CDR2L. (ekstern lenke)
• Giil Lasse Melvær; Dag Aarsland; Kristoffer Herland Hellton et al. (2018). Antibodies to multiple receptors are associated with neuropsychiatric symptoms and mortality in Alzheimer's disease: A longitudinal study. (ekstern lenke)
• Henning Kristian Olberg; Geir Egil Eide; Christian A. Vedeler (2019). Can serum GAD65 antibody levels predict neurological disease or cancer?. (ekstern lenke)
• Magne Solberg Nes; Mette Haugen; Hans Kristian Haugland et al. (2023). Case report: Seropositive myasthenia gravis complicated by limbic encephalitis positive for antibodies to AMPAR and Lgi1. (ekstern lenke)
• Gerd Haga Bringeland; Kjell-Morten Myhr; Christian A. Vedeler et al. (2020). Wearing-off at the end of natalizumab dosing interval and risk of MS disease activity: A prospective 1-year follow-up study. (ekstern lenke)
• Sissel Evy Monstad; Lars Drivsholm; Geir Olve Skeie et al. (2008). CRMP5 antibodies in patients with small-cell lung cancer or thymoma. (ekstern lenke)
• Ida Ajvazi Herdlevær; Torbjørn Kråkenes; Manja Schubert et al. (2020). Localization of CDR2L and CDR2 in paraneoplastic cerebellar degeneration. (ekstern lenke)
• Kristin Nielsen Varhaug; Omar Hikmat; Hanne Linda Nakkestad et al. (2021). Serum biomarkers in primary mitochondrial disorders. (ekstern lenke)
• Cecilie Totland; Torbjørn Kråkenes; Kibret Yimer Mazengia et al. (2018). Expression of the onconeural protein CDR1 in cerebellum and ovarian cancer. (ekstern lenke)
• Debabrata Panja; Christian A. Vedeler; Manja Schubert (2018). Paraneoplastic cerebellar degeneration: Yo antibody alters mitochondrial calcium buffering capacity. (ekstern lenke)
• Margrethe Raspotnig; Christian A. Vedeler; Anette Storstein (2015). Paraneoplastic neurological syndromes in lung cancer patients with or without onconeural antibodies. (ekstern lenke)
• Ulrike Waje-Andreassen; Halvor Næss; Lars Thomassen et al. (2007). Arterial events after ischemic stroke at a young age: A cross-sectional long-term follow-up of patients and controls in western Norway. (ekstern lenke)
• Henning Kristian Olberg; Geir Egil Eide; Rebecca Jane Cox et al. (2018). Antibody response to seasonal influenza vaccination in patients with multiple sclerosis receiving immunomodulatory therapy. (ekstern lenke)
• Gerd Haga Bringeland; Nello Blaser; Kjell-Morten Myhr et al. (2021). Wearing-off symptoms during standard and extended natalizumab dosing intervals: Experiences from the COVID-19 pandemic. (ekstern lenke)
• Maarten Jan Titulaer; Riccardo Soffietti; Josep Dalmau et al. (2011). Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force. (ekstern lenke)
• Eirik Tveit Solheim; Liv Cecilie Vestrheim Thomsen; Line Bjørge et al. (2024). Altered exosomal miRNA profiles in patients with paraneoplastic cerebellar degeneration. (ekstern lenke)
• Cecilie Totland; Nina Karin Aarskog; Tilo Wolf Eichler et al. (2011). CDR2 antigen and Yo antibodies. (ekstern lenke)
• Alina Tomescu-Baciu; Frode Vartdal; Trygve Holmøy et al. (2018). G1m1 predominance of intrathecal virus-specific antibodies in multiple sclerosis. (ekstern lenke)
• Henning Kristian Olberg; Rebecca Jane Cox; Jane Kristin Nøstbakken et al. (2014). Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: An explorative study. (ekstern lenke)
• Christian A. Vedeler; Roald Matre; S. Sadallah et al. (1996). Soluble complement receptor type 1 in serum and cerebrospinal fluid of patients with Guillain-Barr#/e syndrome and multiple sclerosis. (ekstern lenke)
• Nina Karin Aarskog; Christian A. Vedeler (2002). Molekylærgenetisk diagnostikk av Charcot-Marie-Tooth sykdom og hereditær nevropati med trykk pareser. (ekstern lenke)
• Nina Karin Aarskog; Christian A. Vedeler (2001). Recombination breakpoints in the Charcot-Marie-Tooth 1A repeat sequence in Norwegian families. (ekstern lenke)
• Nina Karin Aarskog; Sissel Aadland; Ivar Otto Gjerde et al. (2001). Molecular genetic analysis of Charcot-Marie-Tooth 1A duplication in Norwegian patients by quantitative photostimulated luminiscence imaging. (ekstern lenke)
• Gerd Haga Bringeland; Lucius Bader; Nello Blaser et al. (2019). Optimization of receptor occupancy assays in mass cytometry: Standardization across channels with QSC beads. (ekstern lenke)
• Torunn Fiskerstrand; Dorra H'mida-Ben Brahim; Stefan Johansson et al. (2010). Mutations in ABHD12 Cause the Neurodegenerative Disease PHARC: An Inborn Error of Endocannabinoid Metabolism. (ekstern lenke)
• Christian A. Vedeler; G Conti; T Fujioka et al. (1999). The expression of CD59 in experimental allergic neuritis. (ekstern lenke)
• Henning Kristian Olberg; Mette Haugen; Anette Storstein et al. (2013). Neurological manifestations related to level of voltage-gated potassium channel antibodies. (ekstern lenke)
• Tilo Wolf Eichler; Cecilie Totland; Mette Haugen et al. (2013). CDR2L antibodies: a new player in paraneoplastic cerebellar degeneration. (ekstern lenke)
• Ulrike Waje-Andreassen; Lars Thomassen; Mirza Jusufovic et al. (2013). Ischaemic stroke at a young age is a serious event final results of a population-based long-term follow-up in Western Norway. (ekstern lenke)
• Karl Bjørnar Alstadhaug; Hanne Winge Kvarenes; Jan Fredrik Prytz et al. (2016). A case of relapsing-remitting facial palsy and ipsilateral brachial plexopathy caused by HSV-1. (ekstern lenke)
• Stein-Erik Hafstad Solvang; Jan Erik Nordrehaug; Grethe S. Tell et al. (2019). The kynurenine pathway and cognitive performance in community-dwelling older adults. The Hordaland Health Study. (ekstern lenke)
• Gerd Haga Bringeland; Nello Blaser; Kjell-Morten Myhr et al. (2020). Wearing-off at the end of natalizumab dosing intervals is associated with low receptor occupancy. (ekstern lenke)
• L Bjørge; TS Jensen; E Ulvestad et al. (1995). The influence of tumour necrosis factor-_a, interleukin-1_b and interferon-_g on the expression and function of the complement regulatory protein CD59 on the human colonic adenocarcinoma cell line HT29. (ekstern lenke)
• E. Dietrichs; Christian A. Vedeler (1995). Spesielle interkraniale infeksjoner. (ekstern lenke)
• Kristin Varhaug; Christian A. Vedeler; Charalampos Tzoulis et al. (2017). Multippel sklerose - en mitokondriemediert sykdom?. (ekstern lenke)
• Patrick Waters; Markus Reindl; Albert Saiz et al. (2016). Multicentre comparison of a diagnostic assay: Aquaporin-4 antibodies in neuromyelitis optica. (ekstern lenke)
• Kjell-Morten Myhr; Trond Riise; Christian A. Vedeler et al. (2001). Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension. (ekstern lenke)
• Manja Schubert; Debabrata Panja; Mette Haugen et al. (2014). Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasis. (ekstern lenke)
• Christian A. Vedeler; E. Ulvestad; L. Bjørge et al. (1994). The expression of CD59 in normal human nervous tissue. (ekstern lenke)
• Christian A. Vedeler; E. Ulvestad; H. Nyland et al. (1994). Receptors for gammaglobulin in the central and peripheral nervous system. (ekstern lenke)
• L. Bjørge; Christian A. Vedeler; E. Ulvestad et al. (1994). Expression and function of CD59 on colonic adenocarcinoma cells. (ekstern lenke)
• Kjell-Morten Myhr; G Raknes; Harald Nyland et al. (1999). Immunoglobulin G Fc-receptor (Fc gamma R) IIA and IIIB polymorphisms related to disability in MS. (ekstern lenke)
• Kjell-Morten Myhr; Trond Riise; Elizabeth Barrett-Connor et al. (1998). Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway. (ekstern lenke)
• Nina Karin Aarskog; Tove Marøy; Kjell-Morten Myhr et al. (2009). Antibodies against interferon-beta in multiple sclerosis. (ekstern lenke)
• A. Vatne; Christian A. Vedeler; Ole-Bjørn Tysnes et al. (1994). Varicella zoster-infeksjoner og neurologiske komplikasjoner. (ekstern lenke)
• E. Ulvestad; K. Williams; Christian A. Vedeler et al. (1994). Reactive microglia in multiple sclerosis lesions have an increased expression of receptors for the Fc part of IgG. (ekstern lenke)
• Christian A. Vedeler; Jean-Christophe Antoine; Bruno Giometto et al. (2006). Management of paraneoplastic neurological syndromes: report of an EFNS Task Force. (ekstern lenke)
• Christian A. Vedeler; E. Ulvestad; I. Grundt et al. (1994). Fc receptor for IgG (FcR) on rat microglia. (ekstern lenke)
• Einar Klæboe Kristoffersen; Roald Matre; E. Ulvestad et al. (1994). A dot-immunobinding assay for the demonstration of soluble Fc_g-receptors. (ekstern lenke)
• Ann Cathrine Kroksveen; Astrid Guldbrandsen; Christian A. Vedeler et al. (2012). Cerebrospinal fluid proteome comparison between multiple sclerosis patients and controls. (ekstern lenke)
• Peter Andreas Vold Lossius; Alina Tomescu-Baciu; Trygve Holmøy et al. (2017). Selective intrathecal enrichment of G1m1-positive B cells in multiple sclerosis. (ekstern lenke)
• Lasse Melvær Giil; Einar Klæboe Kristoffersen; Christian A. Vedeler et al. (2015). Autoantibodies toward the angiotensin 2 type 1 receptor: a novel autoantibody in Alzheimer's Disease. (ekstern lenke)
• Torbjørn Kråkenes; Ida Ajvazi Herdlevær; Margrethe Raspotnig et al. (2019). CDR2L Is the Major Yo Antibody Target in Paraneoplastic Cerebellar Degeneration. (ekstern lenke)
• Bjørn Ivar Haukanes; Tor-Arne Hegvik; Tilo Wolf Eichler et al. (2015). Paraneoplastic syndrome-associated neuronal antibodies in adult ADHD. (ekstern lenke)
• Bjarne Magnus Iversen; Christian A. Vedeler; Roald Matre et al. (1993). CR1 activity on erythrocytes and renal glomeruli in patients with renal disorders. (ekstern lenke)
• Anette Storstein; Ivar Otto Gjerde; Christian A. Vedeler et al. (1998). POEMS-syndromet - en sjelden multiorgansykdom. (ekstern lenke)
• Lucius Bader; Stein-Erik Gullaksen; Nello Blaser et al. (2019). Candidate markers for stratification and classification in rheumatoid arthritis. (ekstern lenke)
• Åse Mygland; Torleif Trydal; Bente Urdal Vinje et al. (2007). Isoelectric focusing is superior to immunofixation electrophoresis in diagnosing CNS inflammation. (ekstern lenke)
• Bjarne Magnus Iversen; Christian A. Vedeler; Roald Matre et al. (1993). CR1 activity on erythrocytes and renal glomeruli in patients with renal disorders. (ekstern lenke)
• Bjarne Magnus Iversen; Christian A. Vedeler; Roald Matre et al. (1993). CR1 activity on erythrocytes and renal glomeruli in patients with renal disorders. (ekstern lenke)
• Lucius Bader; Silje Michelsen Solberg; Silje Katrine Helland Kaada et al. (2017). Assays for Infliximab Drug Levels and Antibodies: A Matter of Scales and Categories. (ekstern lenke)
• Mads Aarhus; Ove Bruland; Geir Bredholt et al. (2008). Microarray analysis reveals down-regulation of the tumour suppressor gene WWOX and up-regulation of the oncogene TYMS in intracranial sporadic meningiomas. (ekstern lenke)
• L. Bjørge; T. S. Jensen; Christian A. Vedeler et al. (1993). Soluble CD59 in pregnancy and infancy. (ekstern lenke)
• Elin Hoffmann Dahl; Knut Anders Mosevoll; Dana Cramariuc et al. (2021). COVID-19 myocarditis and postinfection Bell's palsy. (ekstern lenke)
• Kristin Nielsen Varhaug; Torbjørn Kråkenes; Maria Nordheim Alme et al. (2019). Mitochondrial complex IV is lost in neurons in the cuprizone mouse model. (ekstern lenke)
• Ingrid Anne Lie; Sezgi Kacar; Kristin Wesnes et al. (2022). Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal study. (ekstern lenke)
• Giil Lasse Melvær; Christian A. Vedeler; Einar Klæboe Kristoffersen et al. (2017). Antibodies to signaling molecules and receptors in Alzheimer's disease are associated with psychomotor slowing, depression, and poor visuospatial function. (ekstern lenke)
• Cecilie Totland; Jan Harald Aarseth; Christian A. Vedeler (2007). Hu and Yo antibodies have heterogeneous avidity. (ekstern lenke)
• Anette Storstein; Margrethe Raspotnig; Roberta Vitaliani et al. (2016). Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes. (ekstern lenke)
• Anette Knudsen; Sissel Evy Monstad; Anne Dørum et al. (2006). Ri antibodies in patients with breast, ovarian or small cell lung cancer determined by a sensitive immunoprecipitation technique. (ekstern lenke)
• Ida Margrethe Uggerud; Torbjørn Kråkenes; Hirokazu Hirai et al. (2023). Development and Optimization of a Multilayer Rat Purkinje Neuron Culture. (ekstern lenke)
• Silje Johansen; Jostein Kråkenes; Christian Alexander Vedeler et al. (2022). Limbic encephalitis following allogeneic hematopoietic stem cell transplantation. (ekstern lenke)
• Nicole Hartwig Trier; Paul Robert Hansen; Christian A. Vedeler et al. (2012). Identification of continuous epitopes of HuD antibodies related to paraneoplastic diseases/small cell lung cancer. (ekstern lenke)
• Petra Vogelsang; Giil Lasse Melvær; Anders Lund et al. (2018). Reduced glucose transporter-1 in brain derived circulating endothelial cells in mild Alzheimer's disease patients. (ekstern lenke)
• Sissel Evy Monstad; Anette Knudsen; Helga Birgitte Salvesen et al. (2009). Onconeural antibodies in sera from patients with various types of tumours. (ekstern lenke)
• A. Storstein; Christian A. Vedeler; Bård Kronen Krossnes et al. (1997). Paraneoplastisk cerebellar degenerasjon. En kasustikk. (ekstern lenke)
• Geir Bredholt; Anette Margrethe Storstein; Monica Haugen et al. (2006). Detection of autoantibodies to the BTB-kelch protein KLHL7 in cancer sera. (ekstern lenke)
• Sonia Gavasso; Bjørn Tore Gjertsen; Endre Anderssen et al. (2012). Immunogenic effects of recombinant interferon-beta therapy disrupt the JAK/STAT pathway in primary immune cells from patients with multiple sclerosis. (ekstern lenke)
• A. Vatne; Christian A. Vedeler; Ole-Bjørn Tysnes et al. (1994). Varicella zoster-infeksjoner og neurologiske komplikasjoner. (ekstern lenke)

Konferanseabstrakt

• Margrethe Raspotnig; Mette Haugen; Christian A. Vedeler et al. (2012). Paraneoplastic neurological manifestations in patients with lung cancer without onconeural antibodies. (ekstern lenke)
• Christina Sundal; Claes Nordborg; Sven Ekholm et al. (2010). Update of the original pedigree of Hereditary Diffuse Leukoencephalopathy with Spheroids (HDLS). Insights into an underdiagnosed disease entity. (ekstern lenke)
• Cecilie Totland; Nina Karin Aarskog; Mette Haugen et al. (2010). Paraneoplastic Yo antibodies are not related to the presence of cerebellar degeneration-associated CDR2 antigen in ovarian cancer. (ekstern lenke)
• Sonia Gavasso; Tove Helene Marøy; Ellen Færgestad Mosleth et al. (2012). Single cell pStat1 activation, a promising biomarker to evaluate neutralizing antibody effects in interferon-beta treated multiple sclerosis patients. (ekstern lenke)
• Tilo Wolf Eichler; Cecilie Totland; Mette Haugen et al. (2012). Characterization of Yo antibodies. (ekstern lenke)
• Tarja Rajalahti; Reidar Arneberg; Frode Berven et al. (2008). Biomarker discovery from mass spectral profiles: A combined proteomics and multivariate analysis. (ekstern lenke)
• Laurence Bindoff; Torunn Fiskerstrand; D H'mida-Ben Brahim et al. (2010). Genetic characterisation of PHARC - a novel syndrome resembling Refsum's disease. (ekstern lenke)
• Ulrike Waje-Andreassen; Helle Næss; Lars Thomassen et al. (2007). Mortality and vascular morbitity after ischemic stroke at a young age. (ekstern lenke)
• Tor H. Qvale; Anette Storstein; Kibret Yimer Mazengia et al. (2012). Hu antibodies are present in smokers with chronic obstructive pulmonary disease without cancer or neurological disease. (ekstern lenke)
• Sonia Gavasso; Jørn Skavland; Bjørn Tore Gjertsen et al. (2008). Interferon-beta signal transduction, multiple sclerosis and auto-antibodies. (ekstern lenke)
• Tarja Rajalahti; Reidar Arneberg; Frode Berven et al. (2008). Early diagnosis and biomarker discovery from mass spectral profiles: application to multiple sclerosis. (ekstern lenke)
• Anette Knudsen; Geir Bredholt; A. Storstein et al. (2004). CRMP3 antibodies associated with limbic encephalitis and thymoma. (ekstern lenke)
• Cecilie Totland; Geir Bredholt; Mette Haugen et al. (2008). Anti-ccdc104 is a potentially new onconeural antibody. (ekstern lenke)

Vitenskapelig bokkapittel

• Christian A. Vedeler (2003). Paraneoplastiske nevrologiske syndromer. (ekstern lenke)
• Marit Grønning; Christian A. Vedeler (2003). Spinalvæskeundersøkelse. (ekstern lenke)
• Christian A. Vedeler (2015). Acute and Chronic Neuropathies. (ekstern lenke)
• M. Grønning; Christian A. Vedeler (1997). Spinalvæskeundersøkelse. (ekstern lenke)
• Marit Grønning; Christian A. Vedeler (2000). Spinalvæskeundersøkelser. (ekstern lenke)
• Svein Ivar Mellgren; Magnhild Rasmussen; Christian A. Vedeler (2010). Perifere nevropartier. (ekstern lenke)
• Marit Grønning; Christian A. Vedeler (2000). Spinalvæskeundersøkelser. (ekstern lenke)
• HJ Willison; Nils Erik Gilhus; Francesc Graus et al. (2011). Use of antibody testing in nervous system disorders. (ekstern lenke)
• Christian A. Vedeler; Jean-Christophe Antoine; Bruno Giometto et al. (2006). Paraneoplastic syndromes. (ekstern lenke)
• Hugh J. Willison; Nils Erik Gilhus; Francesc Graus et al. (2006). Use of anti-nerve antibodies. (ekstern lenke)

Vitenskapelig litteraturgjennomgang

• Anette Margrethe Storstein; Christian A. Vedeler (2009). Paraneoplastiske nevrologiske syndromer. (ekstern lenke)
• Christian A. Vedeler; Svein Ivar Mellgren; Roald Omdal et al. (2010). Intravenøs IgG-behandling av nevromuskulære sykdommer :. (ekstern lenke)
• Eva M.J. De Boer; Andrew W. Barritt; Marwa Elamin et al. (2021). Facial Onset Sensory and Motor Neuronopathy: New Cases, Cognitive Changes, and Pathophysiology. (ekstern lenke)
• Christian A. Vedeler; Anette Margrethe Storstein (2009). Autoimmune limbic encephalitis. (ekstern lenke)
• Anette Margrethe Storstein; Christian A. Vedeler (2007). Paraneoplastic neurological syndromes and onconeural antibodies: Clinical and immunological aspects. (ekstern lenke)
• Frode Berven; Kristian Flikka; Magnus Foldal Berle et al. (2006). Proteomic-based biomarker discovery with emphasis on cerebrospinal fluid and multiple sclerosis. (ekstern lenke)
• Bruno Giometto; Roberta Vitaliani; Elisabeth Lindeck-Pozza et al. (2012). Treatment for paraneoplastic neuropathies. (ekstern lenke)
• Silje Agnethe Stokke; Stig Wergeland; Øivind Torkildsen et al. (2013). Neuromyelitis optica. (ekstern lenke)
• Kristin Nielsen Varhaug; Øivind Torkildsen; Kjell-Morten Myhr et al. (2019). Neurofilament light chain as a biomarker in multiple sclerosis. (ekstern lenke)
• John E. Greenlee; Noel G. Carlson; Justin R. Abbatemarco et al. (2022). Paraneoplastic and Other Autoimmune Encephalitides: Antineuronal Antibodies, T Lymphocytes, and Questions of Pathogenesis. (ekstern lenke)

Leserbrev

• Anne Kjørsvik Bertelsen; Camilla Tøndel; Jørgen Gitlesen Krohn et al. (2013). Small fibre neuropathy in Fabry disease. (ekstern lenke)
• U Waje-Andreassen; Jostein Kråkenes; Elling Ulvestad et al. (2005). Response to: Interleukin-6 and acute ischaemic stroke. (ekstern lenke)
• Hanne F Harbo; Sverre Mørk; Christian A. Vedeler et al. (2007). Biobank for multippel sklerose etablert. (ekstern lenke)
• Torbjørn Kråkenes; Ida Ajvazi Herdlevær; Margrethe Raspotnig et al. (2020). Reply to “CDR2 and CDR2L Yo Antigens in Paraneoplastic Cerebellar Degeneration”. (ekstern lenke)
• Henning Kristian Olberg; Mette Haugen; Anette Storstein et al. (2013). Neurological manifestations related to level of voltage-gated potassium channel antibodies. (ekstern lenke)
• Tilo Wolf Eichler; Cecilie Totland; Mette Haugen et al. (2018). CCDC104 Antibodies and Mitosis of Cancer Cells. (ekstern lenke)
• Christina Heidemann Sundal; Christian A. Vedeler; Hrvoje Miletic et al. (2017). Morvan syndrome with Caspr2 antibodies. Clinical and autopsy report. (ekstern lenke)
• Christian A. Vedeler; Laurence Bindoff (2011). A family with atypical CADASIL. (ekstern lenke)

Doktorgradsavhandling

• Nina Karin Aarskog; Christian A. Vedeler (2002). Molecular diagnostic aspects of Charcot-Marie-Tooth disease. (ekstern lenke)
• Giil Lasse Melvær; Jan Erik Nordrehaug; Dag Aarsland et al. (2019). Antibodies to Signaling Molecules and Receptors in Alzheimer’s Disease. (ekstern lenke)
• Christian A. Vedeler (1990). Receptors for IgG and for C3b/C4b in human peripheral nerves. (ekstern lenke)

Konferanseposter

• Nina Karin Aarskog; Sidsel Aadland; Christian A. Vedeler (2000). Molecular genetic analysis of Charcot-Marie-Tooth 1A duplication in Norwegian patients by quantitative photostimulated luminescence imaging. (ekstern lenke)
• Sonia Gavasso; Nina Karin Aarskog; Kjell-Morten Myhr et al. (2004). Fc gamma receptor expression of peripheral leukocytes in Multiple Sclerosis patients treated with interferon-beta or glatiramer acetate.. (ekstern lenke)
• Kjell Arne Arntzen; Helle Høyer; Kristin Ørstavik et al. (2018). Clinical characteristics, minimum prevalence and spectrum of SH3TC2 mutations in Norway. (ekstern lenke)
• Johan G Brun; TM Madland; Christian A. Vedeler (1999). Immunoglobulin G Fc-receptor (FC_gR) IIA and IIIB polymorphisms related to disease severity in rheumatoid arthritis. (ekstern lenke)
• Kjell-Morten Myhr; Trond Riise; Christian A. Vedeler et al. (1996). Long-term prognosis in a incidence cohort of 219 multiple sclerosis patients from Hordaland county, Western Norway. (ekstern lenke)

Masteroppgave

• Eirik Tveit Solheim; Cecilie Totland; Christian A. Vedeler (2018). Subcellular Localization of Cerebellar Degeneration Related Protein 1 in Breast and Ovarian Cancer Cell Lines. (ekstern lenke)
• Ida Margrethe Uggerud; Manja Schubert; Christian A. Vedeler (2018). Purkinje neuron dendritic arbour development and morphological changes induced by paraneoplastic cerebellar degeneration related autoantibody Yo. (ekstern lenke)

Populærvitenskapelig artikkel

• Christian A. Vedeler (1991). Rapport fra studieopphold i USA. (ekstern lenke)
• Christian A. Vedeler (1998). Evaluering av undervisning i nevrologi. (ekstern lenke)
• Christian A. Vedeler (1998). Evaluering av undervisning i nevrologi. (ekstern lenke)
• Christian A. Vedeler (1997). Genetisk kartlegging av multippel sklerose. (ekstern lenke)

Fagartikkel

• Andreas Lahelle; Mari Ellefsen-Martinsen; Hanne Ludt Fossmo et al. (2022). Trening og fysisk aktivitet for personer med Charcot-Marie-Tooth sykdom. (ekstern lenke)
• Thomas Totland Moss; Knut Stavem; Astrid Aandahl et al. (2023). Case Report: Limbic encephalitis following treatment with durvalumab for small-cell lung cancer. (ekstern lenke)
• Kirsti Ytrehus; Liv Ariane Augestad; Tor-Arne Hagve et al. (2014). Satsingen på medisinsk forskning kan bli svekket. (ekstern lenke)

Kasusrapport

• Magne Solberg Nes; Jogrim Søyland; Mette Haugen et al. (2025). En mann i 70-årene med svekket kraft og følelse i beina. (ekstern lenke)

Lederartikkel

• Anette Margrethe Storstein; BK Krossnes; Christian A. Vedeler (2009). Morphological and immunohistochemical characterization of paraneoplastic cerebellar degeneration associated with Yo antibodies. (ekstern lenke)
• Anette Margrethe Storstein; Bård Kronen Krossnes; Christian A. Vedeler (2009). Morphological and immunohistochemical characterization of paraneoplastic cerebellar degeneration associated with Yo antibodies. (ekstern lenke)
• John E. Greenlee; Noel G. Carlson; Justin R. Abbatemarco et al. (2022). Editorial: Autoimmunity and the Brain: Paraneoplastic Neurological Injury and Beyond. (ekstern lenke)

Konferanseforedrag

• Tarja Rajalahti; Reidar Arneberg; Kristian Flikka et al. (2007). Preteatment of Mass Spectral Profiles: Application to proteomic data. (ekstern lenke)
• Olav Martin Kvalheim; Tarja Rajalahti; Reidar Arneberg et al. (2007). Analysis of Proteomic Profiles. (ekstern lenke)
• Olav Martin Kvalheim; Tarja Rajalahti; Reidar Arneberg et al. (2007). Target projection and proper data pre-treatment for the analysis of proteomic profiles. (ekstern lenke)
• Kjell-Morten Myhr; Trond Riise; Christian A. Vedeler et al. (1995). Lomg-term prognosis in a incidence cohort of 219 Multiple Sclerosis patients from Hordaland county, Western Norway. (ekstern lenke)

Fremhevet artikkel i media

• L. Bjørge; T. Skeie Jensen; Christian A. Vedeler et al. (1993). Soluble CD59 in pregnancy and infancy. (ekstern lenke)

Se en fullstendig oversikt over publikasjoner i NVA.

Biomarkers and Neuroimmunology